The Jobs-to-be-Done framework reveals that employers do not buy messaging; they buy the reduction of avoidable medical claims and absenteeism. Evive Health addresses the gap between health insurance coverage and employee action. However, the Bargaining Power of Buyers is high because large employers can choose between various wellness vendors. The Threat of Substitutes is significant as health insurance carriers are building their own internal nudge capabilities.
Option 1: The Chronic Care Pivot. Shift focus from seasonal influenza to high-cost chronic conditions like diabetes and hypertension. This increases the value proposition from a one-time event to year-round management.
Trade-offs: Requires deeper data integration and higher clinical expertise.
Resources: Enhanced data science team and clinical consultants.
Option 2: Digital-First Transformation. Phase out physical mailers in favor of a mobile application and SMS-based nudges.
Trade-offs: Lower cost of goods sold but risks lower engagement among older workforce demographics.
Resources: Software development and UX design investment.
Evive Health must pursue Option 1. The influenza experiment proves the efficacy of the nudge, but the financial impact of flu is small compared to chronic disease. By applying the same behavioral economics to medication adherence and regular screenings, Evive can justify a 3x increase in PMPM fees. The company must move from being a tactical vendor to a strategic partner in population health management.
The transition will follow a phased rollout. To mitigate data latency, Evive will prioritize pharmacy data over medical claims data, as pharmacy triggers are more frequent and timely. To address privacy concerns, all communications will emphasize employee benefit and remain strictly opt-out. The plan includes a 15 percent buffer in the development timeline to account for the complexity of integrating diverse data formats from different insurance carriers.
Evive Health must pivot from seasonal flu interventions to chronic disease management to secure long-term viability. The 2012 experiment confirms that personalized nudges increase vaccination rates, but flu shots alone cannot sustain a high-margin PMPM model. The path forward requires applying these behavioral insights to high-cost, year-round health issues like diabetes and cardiovascular health. This shift transforms Evive from a niche messaging service into a critical component of the employer healthcare value chain. Success depends on reducing data latency and expanding the nudge library to address complex health behaviors.
The analysis assumes that the high response rate to physical mailers for a simple, one-time action like a flu shot will translate to complex, repetitive behaviors required for chronic disease management. Behavioral economics suggests that the friction for daily medication adherence is significantly higher than for a single annual injection.
The team did not evaluate a B2C model. Instead of selling to employers, Evive could partner directly with pharmacy benefit managers to nudge consumers at the point of sale or via retail pharmacy apps. This would bypass the slow employer sales cycle and provide access to more immediate behavioral data.
APPROVED FOR LEADERSHIP REVIEW
Qualico: Building a Path Forward custom case study solution
On Balance, Who's the Better Manager? custom case study solution
Jazz: The Journey Towards Diversity, Equity, and Inclusion custom case study solution
Robot Rumors: Should I Be Worried? custom case study solution
M&A Deal Structuring custom case study solution
Included Health: A Vision for Integrated Care in America custom case study solution
Future-proofing Roche: Transforming for agility and empowerment custom case study solution
Claw and Kitty: Gripping a Potential Expansion custom case study solution
Shall Indian Railways Reform, Collaborate and Perform with Startups? custom case study solution
BeefLedger: Cross-Border Beef Supply Chain Based on Blockchain Technology custom case study solution
Alibaba's IPO Dilemma: Hong Kong or New York? custom case study solution
Denka Chemicals custom case study solution